Walgreens Boots Alliance Inc (NASDAQ:WBA) has earned an average recommendation of “Hold” from the twenty-two ratings firms that are presently covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a sell recommendation, twelve have given a hold recommendation and five have given a buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $78.31.
Several equities research analysts have recently issued reports on the company. Barclays raised their price target on Walgreens Boots Alliance from $77.00 to $80.00 and gave the company an “equal weight” rating in a research report on Friday, October 12th. Citigroup increased their target price on shares of Walgreens Boots Alliance from $69.00 to $76.00 and gave the company a “neutral” rating in a research note on Friday, October 12th. Zacks Investment Research cut shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research note on Wednesday, December 12th. Loop Capital set a $82.00 target price on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Thursday, December 20th. Finally, SunTrust Banks increased their target price on shares of Walgreens Boots Alliance to $75.00 and gave the company a “hold” rating in a research note on Friday, October 12th.
In other Walgreens Boots Alliance news, EVP Kathleen Wilson-Thompson sold 52,000 shares of the firm’s stock in a transaction dated Wednesday, October 31st. The shares were sold at an average price of $78.77, for a total transaction of $4,096,040.00. Following the completion of the transaction, the executive vice president now owns 81,076 shares in the company, valued at $6,386,356.52. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Kimberly R. Scardino sold 11,970 shares of the firm’s stock in a transaction dated Thursday, November 1st. The stock was sold at an average price of $79.79, for a total transaction of $955,086.30. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 73,756 shares of company stock valued at $5,824,194. Corporate insiders own 15.73% of the company’s stock.
Shares of NASDAQ:WBA traded down $0.99 during midday trading on Friday, hitting $71.49. The company’s stock had a trading volume of 417,205 shares, compared to its average volume of 7,338,223. The company has a market cap of $68.15 billion, a P/E ratio of 11.86, a P/E/G ratio of 1.13 and a beta of 0.99. Walgreens Boots Alliance has a fifty-two week low of $59.07 and a fifty-two week high of $86.31. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.36 and a current ratio of 0.80.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, December 20th. The pharmacy operator reported $1.46 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.43 by $0.03. The company had revenue of $33.79 billion for the quarter, compared to the consensus estimate of $33.90 billion. Walgreens Boots Alliance had a return on equity of 22.17% and a net margin of 3.96%. The firm’s revenue was up 9.9% compared to the same quarter last year. During the same period last year, the business posted $1.28 earnings per share. As a group, equities analysts predict that Walgreens Boots Alliance will post 6.52 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Wednesday, December 12th. Investors of record on Monday, November 12th were paid a $0.44 dividend. This represents a $1.76 annualized dividend and a dividend yield of 2.46%. The ex-dividend date was Thursday, November 8th. Walgreens Boots Alliance’s payout ratio is presently 29.24%.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Further Reading: Asset Allocation
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.